Paul D. Maroni

Paul D. Maroni

Oncology | Urology
1665 Aurora Ct
1st Floor
Aurora, CO 80045

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathways.

Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathways.

Journal: The Canadian journal of urology
Published: April 20, 2024

Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer.

Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer.

Journal: JCO oncology practice
Published: December 21, 2023

Differential Effect of Non-Steroidal Anti-Inflammatory Drugs Aspirin and Naproxen against TMPRSS2-ERG (Fusion)-Driven and Non-Fusion-Driven Prostate Cancer.

Differential Effect of Non-Steroidal Anti-Inflammatory Drugs Aspirin and Naproxen against TMPRSS2-ERG (Fusion)-Driven and Non-Fusion-Driven Prostate Cancer.

Journal: Cancers
Published: September 26, 2023

NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.

NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 10, 2023

Multifocal Paraganglioma in Teenager Presenting With Hypertension.

Multifocal Paraganglioma in Teenager Presenting With Hypertension.

Journal: Urology
Published: October 03, 2022

Stage-Specific Effect of Inositol Hexaphosphate on Cancer Stem Cell Pool during Growth and Progression of Prostate Tumorigenesis in TRAMP Model.

Stage-Specific Effect of Inositol Hexaphosphate on Cancer Stem Cell Pool during Growth and Progression of Prostate Tumorigenesis in TRAMP Model.

Journal: Cancers
Published: July 01, 2022

Retraction Note: Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostate cancer.

Retraction Note: Hypoxia-associated p38 mitogen-activated protein kinase-mediated androgen receptor activation and increased HIF-1α levels contribute to emergence of an aggressive phenotype in prostate cancer.

Journal: Oncogene
Published: May 19, 2022

Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models.

Characterization of stage-specific tumor progression in TMPRSS2-ERG (fusion)-driven and non-fusion-driven prostate cancer in GEM models.

Journal: Molecular carcinogenesis
Published: March 09, 2022

Stage-specific differential expression of zinc transporter SLC30A and SLC39A family proteins during prostate tumorigenesis.

Stage-specific differential expression of zinc transporter SLC30A and SLC39A family proteins during prostate tumorigenesis.

Journal: Molecular carcinogenesis
Published: November 23, 2021

Retraction Note to: Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF.

Retraction Note to: Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF.

Journal: Molecular cancer
Published: August 28, 2021

Median Lobe Urethral Embolus After Focal Ablation of Gleason 7 Prostate Cancer.

Median Lobe Urethral Embolus After Focal Ablation of Gleason 7 Prostate Cancer.

Journal: Oncology (Williston Park, N.Y.)
Published: July 15, 2021

Comparative effectiveness of robotic and open radical prostatectomy.

Comparative effectiveness of robotic and open radical prostatectomy.

Journal: Translational andrology and urology
Published: June 23, 2021
Showing 1-12 of 52

Last Updated: 09/26/2026